Items Tagged ‘HER2’

Biomarkers 101 Part 2

July 1, 2014

Biomarkers 101 Part 2

By AJ Montpetit AJ Montpetit

    George Vasmatzis, Ph.D., and John Cheville, M.D., co-directors of the Biomarker Program at the Center for Individualized Medicine at Mayo Clinic, introduce us to the world and work of Biomarkers. The Biomarker Discovery Program is a multidisciplinary team that includes oncologists, surgeons, pathologists, molecular biologists, bioengineers, bioinformaticians and others. By combining expertise, the program takes a clinical […]

View full entry

Tags: biomarker, Biomarker Discovery Program, biomarkers, Bladder Cancer, breast cancer, center for individualized medicine, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics


January 21, 2014

Genomics Opens Door for New Application of Breast Cancer Drug for Bladder Cancer Patients

By Mystery User

Researchers at Mayo Clinic have found amplification of the gene HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that it’s presence is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, […]

View full entry

Tags: biomarker, Biomarker Discovery Program, biomarkers, Bladder Cancer, breast cancer, center for individualized medicine, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics


Contact Us · Privacy Policy